Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J H Webborn

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioanalysis|October 30, 2015
Future directions of imaging MS in pharmaceutical R&DRichard J A Goodwin, Peter J H Webborn
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2008
Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytesKen Grime, Peter J H Webborn, Robert J Riley
Molecular Pharmaceutics|May 1, 2009
Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industryMathew G Soars, Peter J H Webborn, Robert J Riley
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposureGregory S Basarab, Pamela J Hill, Abdullah Rastagar, et al.
Plos Pathogens|April 22, 2021
Actives from MMV Open Access Boxes? A suggested way forwardKirandeep Samby, Paul A Willis, Jeremy N Burrows, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivoMatthew G Soars, Ken Grime, Joanne L Sproston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytesStuart W Paine, Alison J Parker, Philip Gardiner, et al.
Drug Metabolism Reviews|June 16, 2012
The right compound in the right assay at the right time: an integrated discovery DMPK strategyPeter Ballard, Patrick Brassil, Khanh H Bui, et al.
Scientific Reports|November 25, 2016
Spatial Quantitation of Drugs in tissues using Liquid Extraction Surface Analysis Mass Spectrometry ImagingJohn G Swales, Nicole Strittmatter, James W Tucker, et al.
Analytical Chemistry|September 10, 2015
Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imagingJohn G Swales, James W Tucker, Michael J Spreadborough, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioanalysis|October 30, 2015
Future directions of imaging MS in pharmaceutical R&DRichard J A Goodwin, Peter J H Webborn
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2008
Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytesKen Grime, Peter J H Webborn, Robert J Riley
Molecular Pharmaceutics|May 1, 2009
Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industryMathew G Soars, Peter J H Webborn, Robert J Riley
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposureGregory S Basarab, Pamela J Hill, Abdullah Rastagar, et al.
Plos Pathogens|April 22, 2021
Actives from MMV Open Access Boxes? A suggested way forwardKirandeep Samby, Paul A Willis, Jeremy N Burrows, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivoMatthew G Soars, Ken Grime, Joanne L Sproston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytesStuart W Paine, Alison J Parker, Philip Gardiner, et al.
Drug Metabolism Reviews|June 16, 2012
The right compound in the right assay at the right time: an integrated discovery DMPK strategyPeter Ballard, Patrick Brassil, Khanh H Bui, et al.
Scientific Reports|November 25, 2016
Spatial Quantitation of Drugs in tissues using Liquid Extraction Surface Analysis Mass Spectrometry ImagingJohn G Swales, Nicole Strittmatter, James W Tucker, et al.
Analytical Chemistry|September 10, 2015
Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imagingJohn G Swales, James W Tucker, Michael J Spreadborough, et al.
Pageof 2